drugset
drugset / Trial / NCT01334905

A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers

NCT01334905 ↗

Phase 1 Completed 12 enrolled Astellas Pharma Inc Astellas Pharma Taiwan, Inc. · collab
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate safety of YM178 and the effect of food intake on the pharmacokinetics of YM178 in healthy adult subjects.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified — Oral

Indications

No indication recorded.